Fisher Wallace Laboratories on StartEngine

Medical Devices for Mood and Sleep

Raise to date: $397,053

Reporting Date: 12/04/2019

Key Stats

Minimum Raise

$10,000

Maximum Raise

$1,070,000

Likelihood of Max Unlikely
Start Date

10/08/2019

Stop Date

01/07/2020

Days Remaining

32

Security Type

Equity

Investment Minimum

$250

Deal Type

Deal to Watch


Investment Summary

Status

Active

# of Investors

475

% of Minimum Raised

3,971%

% of Maximum Raised

37%

Dollars Per Day to Reach Max

$21,030

DPD* Committed

$6,966

DPD* Category

$0

DPD* All Companies

$1,428

Kingscrowd Momentum

$397,053

Total Dollars Raised

Commitments

Weekly Commitments ($)
Aggregate Commitments ($)

SEC Filing Data from Kingscrowd

Fisher Wallace Laboratories, with a pre-money valuation of $15 million, is raising funds on StartEngine. The company is developing an FDA-cleared, clinically validated, wearable treatment for insomnia, anxiety, and depression. The Fisher Wallace Stimulator stimulates the brain to produce more serotonin and other neurochemicals, and less cortisol. The device has shown to have 75% effectiveness and only 1% side effects in clinical trials and practice. Fisher Wallace Laboratories was founded by Kelly Roman and Charles Fisher in 2007. The proceeds of the current crowdfunding round, with a minimum goal of $10,000 and a maximum goal of $1,070,000, will be used to continue the development of Version 2 device and to grow the sales of Version 1. Fisher Wallace Laboratories already has lifetime revenues of $23.3 million, with $4.7 million of net revenue in 2018.

INVEST NOW